Markel Group (NYSE:MKL) Stock Unloaded Rep. Thomas H. Kean, Jr.

Representative Thomas H. Kean, Jr. (Republican-New Jersey) recently sold shares of Markel Group Inc. (NYSE:MKL). In a filing disclosed on February 19th, the Representative disclosed that they had sold between $15,001 and $50,000 in Markel Group stock on January 23rd. The trade occurred in the Representative’s “STATE STREET BANK & TRUST CO.” account.

Representative Thomas H. Kean, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 1/29/2026.
• Sold $15,001 – $50,000 in shares of Stryker (NYSE:SYK) on 1/23/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/23/2026.
• Sold $15,001 – $50,000 in shares of Johnson & Johnson (NYSE:JNJ) on 1/23/2026.
• Sold $1,001 – $15,000 in shares of General Motors (NYSE:GM) on 1/7/2026.
• Purchased $1,001 – $15,000 in shares of Texas Instruments (NASDAQ:TXN) on 11/26/2025.

Markel Group Trading Down 0.9%

Shares of MKL stock opened at $2,064.16 on Tuesday. The business has a 50-day moving average of $2,100.32 and a 200 day moving average of $2,018.15. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.60 and a quick ratio of 0.60. Markel Group Inc. has a 1-year low of $1,621.89 and a 1-year high of $2,207.59. The stock has a market capitalization of $26.03 billion, a PE ratio of 12.16 and a beta of 0.79.

Analysts Set New Price Targets

A number of analysts have recently weighed in on MKL shares. Weiss Ratings reissued a “buy (b+)” rating on shares of Markel Group in a research note on Monday, December 29th. Zacks Research cut shares of Markel Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, January 19th. Finally, Truist Financial boosted their price objective on shares of Markel Group from $2,000.00 to $2,100.00 and gave the company a “hold” rating in a research report on Friday, February 6th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $2,100.00.

Institutional Trading of Markel Group

Several large investors have recently added to or reduced their stakes in MKL. Compound Planning Inc. lifted its position in shares of Markel Group by 1.8% in the 4th quarter. Compound Planning Inc. now owns 615 shares of the insurance provider’s stock worth $1,322,000 after purchasing an additional 11 shares during the period. Invesco Ltd. increased its position in shares of Markel Group by 2.1% during the fourth quarter. Invesco Ltd. now owns 19,158 shares of the insurance provider’s stock valued at $41,183,000 after buying an additional 392 shares during the period. Corient Private Wealth LLC raised its stake in Markel Group by 8.0% in the fourth quarter. Corient Private Wealth LLC now owns 3,581 shares of the insurance provider’s stock worth $7,698,000 after buying an additional 264 shares in the last quarter. Strive Financial Group LLC purchased a new stake in Markel Group in the fourth quarter worth about $234,000. Finally, Mercer Global Advisors Inc. ADV boosted its position in Markel Group by 2.2% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 1,765 shares of the insurance provider’s stock valued at $3,795,000 after acquiring an additional 38 shares in the last quarter. Institutional investors own 77.12% of the company’s stock.

Insider Buying and Selling at Markel Group

In other news, Director Steven A. Markel sold 1,330 shares of the stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $2,119.12, for a total value of $2,818,429.60. Following the completion of the transaction, the director owned 60,368 shares of the company’s stock, valued at approximately $127,927,036.16. This represents a 2.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders sold 1,500 shares of company stock worth $3,175,430. 1.66% of the stock is currently owned by corporate insiders.

About Representative Kean

Thomas Kean Jr. (Republican Party) is a member of the U.S. House, representing New Jersey’s 7th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Kean (Republican Party) is running for re-election to the U.S. House to represent New Jersey’s 7th Congressional District. He declared candidacy for the 2026 election.

Thomas Kean Jr. lives in Westfield, New Jersey. Kean earned a master’s degree from the Tufts University Fletcher School of Law and Diplomacy. His career experience includes working with the Environmental Protection Agency during the George H.W. Bush administration and as an advisor to former U.S. Representative Bob Franks, a firefighter, and an emergency medical technician. Kean has served as the vice president of a fire department.

Markel Group Company Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.